• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌细胞化疗过程中生存素信使核糖核酸水平的变化

Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells.

作者信息

Wang Zehua, Xie Yanhua, Wang Hongbo

机构信息

Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefong Dadoo, Wuhan, China.

出版信息

Cancer Biol Ther. 2005 Jul;4(7):716-9. doi: 10.4161/cbt.4.7.1782. Epub 2005 Jul 2.

DOI:10.4161/cbt.4.7.1782
PMID:15970709
Abstract

OBJECTIVE

To investigate the role of antiapoptosis gene, survivin involved in regulating cell sensitivity to taxanes and platinum compounds.

METHODS

Cultured human epithelial ovarian cancer cell line A2780 and its platinum(DDP)-resistance cell line A2780/DDP were divided into three groups as control, treatment with DDP, and treatment with Taxol Expression of mdr1 and survivin genes in each group was detected by using reverse transcription-polymerase chain reaction (RT-PCR). Apoptosis in the ovarian cancer cell lines was measured by flow cytometry.

RESULTS

After treatment with DDP for 48 h, relative survivin expression was significantly lower than that of no drug given (p<0.05). In A2780/DDP cells, expression of Survivn was obviously higher than that of the control group (P<0.05) after treatment of DDP for 48 h. Interestingly, survivin mRNA level was significantly decreased after treatment with Taxol for 48 h in the A2780/DDP-Taxol group compared with that in the control group. Apoptosis rate of A2780 cells was significantly increased to 46.21% and 44.46%, respectively, with treatment of DDP and Taxol. However, apoptosis rate in A2780/DDP was only 20.04% after DDP treatment for 48 h, demonstrating the presence of resistance to DDP in A2780/DDP cells.

CONCLUSIONS

This study demonstrated that changes in survivin mRNA level were related to the chemotherapy-induced apoptosis. Survivin may be considered as a biological indicator of the chemo-resistance of ovarian cancer.

摘要

目的

探讨抗凋亡基因生存素(survivin)在调节细胞对紫杉烷类和铂类化合物敏感性中的作用。

方法

将培养的人上皮性卵巢癌细胞系A2780及其铂(顺铂,DDP)耐药细胞系A2780/DDP分为三组,即对照组、DDP处理组和紫杉醇处理组。采用逆转录-聚合酶链反应(RT-PCR)检测各组中多药耐药基因1(mdr1)和生存素基因的表达。通过流式细胞术检测卵巢癌细胞系中的细胞凋亡情况。

结果

DDP处理48小时后,生存素相对表达量显著低于未给药组(p<0.05)。在A2780/DDP细胞中,DDP处理48小时后,生存素表达明显高于对照组(P<0.05)。有趣的是,与对照组相比,A2780/DDP-紫杉醇组经紫杉醇处理48小时后,生存素mRNA水平显著降低。A2780细胞经DDP和紫杉醇处理后,凋亡率分别显著升高至46.21%和44.46%。然而,A2780/DDP细胞经DDP处理48小时后凋亡率仅为20.04%,表明A2780/DDP细胞对DDP存在耐药性。

结论

本研究表明生存素mRNA水平的变化与化疗诱导的细胞凋亡有关。生存素可被视为卵巢癌化疗耐药的生物学指标。

相似文献

1
Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells.卵巢癌细胞化疗过程中生存素信使核糖核酸水平的变化
Cancer Biol Ther. 2005 Jul;4(7):716-9. doi: 10.4161/cbt.4.7.1782. Epub 2005 Jul 2.
2
MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells.多药耐药基因1和多药耐药基因3与卵巢癌细胞对顺铂的耐药性
J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):721-4. doi: 10.1007/s11596-007-0627-7.
3
[RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM].[RNA干扰沉默生存素基因表达并逆转卵巢癌细胞系SKOV3/ADM的耐药性]
Zhonghua Fu Chan Ke Za Zhi. 2005 Dec;40(12):836-9.
4
[Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].生存素小干扰RNA对卵巢癌细胞SKOV3/DDP生长、凋亡及化疗敏感性的影响
Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):174-7.
5
[Inhibitory effects of survivin antisense oligonucleotide on drug-resistant human ovarian cancer cell COC1/DDP].生存素反义寡核苷酸对耐药人卵巢癌细胞COC1/DDP的抑制作用
Ai Zheng. 2004 Aug;23(8):896-9.
6
[Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].生存素短发夹RNA对人卵巢癌细胞系OVCAR3对紫杉醇化疗敏感性的影响
Ai Zheng. 2006 Apr;25(4):398-403.
7
[Reversal effect of Fe3O4-magnetic nanoparticles on multi-drug resistance of ovarian carcinoma cells and its correlation with apoptosis-associated genes].[Fe3O4磁性纳米颗粒对卵巢癌细胞多药耐药性的逆转作用及其与凋亡相关基因的相关性]
Ai Zheng. 2009 Nov;28(11):1158-62. doi: 10.5732/cjc.009.10090.
8
Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.长链非编码 RNA CCAT1 通过调控存活素促进卵巢癌细胞对顺铂的化疗耐药性
Cancer Res Treat. 2020 Jul;52(3):798-814. doi: 10.4143/crt.2019.498. Epub 2020 Mar 3.
9
Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.抗生存素寡核苷酸诱导人卵巢上皮癌细胞凋亡
Oncol Rep. 2005 Jul;14(1):275-9.
10
[Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel].[MDR1和MDR3基因沉默对A2780/紫杉醇细胞紫杉醇耐药性的逆转作用]
Zhonghua Fu Chan Ke Za Zhi. 2007 Jun;42(6):412-6.

引用本文的文献

1
Involvement of AKT/PI3K Pathway in Sanguinarine's Induced Apoptosis and Cell Cycle Arrest in Triple-negative Breast Cancer Cells.血根碱诱导三阴性乳腺癌细胞凋亡和细胞周期阻滞涉及 AKT/PI3K 通路。
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):323-342. doi: 10.21873/cgp.20385.
2
Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.与橄榄苦苷诱导的三阴性乳腺癌细胞增殖抑制作用和 S 期细胞周期阻滞相关的基因表达变化。
Nutrients. 2020 Dec 7;12(12):3755. doi: 10.3390/nu12123755.
3
Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
生存素小干扰RNA增加卵巢癌细胞原代培养物对紫杉醇的敏感性。
Clin Transl Oncol. 2015 Sep;17(9):737-42. doi: 10.1007/s12094-015-1302-2. Epub 2015 Jun 2.
4
Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer.共载抗生存素小干扰RNA和紫杉醇的多功能聚合物胶束克服卵巢癌动物模型中的耐药性
Mol Cancer Ther. 2015 Apr;14(4):1075-84. doi: 10.1158/1535-7163.MCT-14-0556. Epub 2015 Feb 5.
5
Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo.姜黄素对人结肠癌多药耐药的体内外作用。
Clinics (Sao Paulo). 2013 May;68(5):694-701. doi: 10.6061/clinics/2013(05)18.